Aarhus University logo

  • About
    • About the Nordic EMBL Partnership
    • Mission statement
    • EMBL non-tenure model
    • Contact
  • News
  • Collaborations
    • NordForsk: Nordic EMBL Partnership Hub
    • How the Nordic EMBL Partnership is helping to fight COVID-19
    • Tools of the Trade Data Science Webinar Series
    • Nordic EMBL Partnership Meetings
    • Nordic EMBL Partnership Science and Art
  • Research
  • Technologies
  • Training
  • Careers
  • Internal

DANDRITE

The Danish Research Institute of Translational Neuroscience (DANDRITE) is the Danish node of the Nordic EMBL Partnership, and performs basic and translational research in brain and the nervous system.

FIMM

The Institute for Molecular Medicine Finland (FIMM) is the Finnish node of the Nordic EMBL Partnership. FIMM’s research interests are human genomics and personalized medicine, with a focus on translational research.

MIMS

The Laboratory for Molecular Infection Medicine Sweden (MIMS) is the Swedish node of the Nordic EMBL Partnership. MIMS aims to strengthen Swedish research and enhance the dynamics in the field of molecular medicine.

NCMM

Centre for Molecular Medicine Norway (NCMM) is the Norwegian node of the Nordic EMBL Partnership. NCMM conducts molecular medicine & biotech research and works translate these findings into clinical practice. 

Latest News


Building Bridges 2023 - Connecting researchers to strengthen crisis preparedness

BUILDING BRIDGES 2023: CRISIS PREPAREDNESS USING THE COVID-19 PANDEMIC AS AN EXAMPLE
29 March 2023 - Knowledge exchange

On 16 March 2023, the Finnish node of the Nordic EMBL Partnership for Molecular Medicine, FIMM, together with the Doctoral Program in Clinical…

DANDRITE through 10 years: Making history with the future of Neuroscience

Photo: Lise Balsby, AU Photo
17 March 2023 - News type

This month DANDRITE celebrates 10 years of existence. With a new generation of highly talented group leaders already recruited, the research center is…

Anthony Mathelier appointed as the new Associate Director of NCMM

NCMM's new Associate Director Anthony Mathelier. Photo: Oda Hveem
22 February 2023 - Knowledge exchange

NCMM group leader Anthony Mathelier will be the new Associate Director of the Centre, combined with a part-time Professor II position at the Centre…

Clinical study demonstrates the efficacy of a drug sensitivity test in predicting treatment response in leukemia

A microscopic image of a bone marrow sample from an AML patient. Image by Heikki Kuusanmäki.
16 February 2023 - Research news

A clinical trial performed in Finland has shown that a drug sensitivity test performed on patient's own cells in laboratory conditions predicts…

Page 3 of 54.

  • Previous
  • 1
  • 2
  • 3
  • 4
  • …
  • 54
  • Next

Upcoming Partnership Events


Tweets by Nordic EMBL
Follow @NordicEMBL

 

About 

News 

Collaborations

Research

Technologies

Training

Careers

 

 

 

Follow us

Twitter: @NordicEMBL

Facebook.com/NordicEMBL

linkedin.com/company/nordic-embl-partnership-for-molecular-medicine

 

The Nordic EMBL Partnership for Molecular Medicine combines the complementary research expertise of the Nordic countries with a common aim to address some of the biggest challenges in biomedicine today.

 

Revised 06.04.2022

© — Cookies at au.dk
Privacy Policy
Accessibility Statement

15450 / i43